Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT05040373
Patisiran-Lipid Nanoparticle (LNP) Pregnancy Surveillance Program
Sponsor: Alnylam Pharmaceuticals
View on ClinicalTrials.gov
Summary
The purpose of this study is to collect and evaluate pregnancy outcomes, pregnancy complications, and fetal/neonatal/infant outcomes in women exposed to patisiran-LNP.
Official title: Patisiran-LNP Pregnancy Surveillance Program
Key Details
Gender
FEMALE
Age Range
Any - Any
Study Type
OBSERVATIONAL
Enrollment
10
Start Date
2020-08-01
Completion Date
2030-10-12
Last Updated
2026-03-31
Healthy Volunteers
No
Locations (7)
Clinical Trial Site
Iowa City, Iowa, United States
Clinical Trial Site
Nantes, France
Clinical Trial Site
Münster, Germany
Clinical Trial Site
Pavia, Italy
Clinical Trial Site
Groningen, Netherlands
Clinical Trial Site
Lisbon, Portugal
Clinical Trial Site
Madrid, Spain